ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Share Fallers
Why CIMIC, oOh!Media, ResMed, & Resolute shares are dropping lower
Share Market News
These were the worst performing ASX shares last week
Share Market News
ASX 200 Weekly Wrap: Surging commodity prices snap ASX 200's losing streak
⏸️ ASX Shares
Why ResMed shares could be a fantastic buy and hold option
Share Market News
Top brokers name 3 ASX shares to sell next week
Share Fallers
These were the worst performing ASX 200 shares last week
Motley Fool Take Stock
Ready for the "80% stock market crash"?
Share Fallers
The latest ASX 200 stocks downgraded by top brokers
⏸️ Investing
Is the ResMed share price a buy?
Share Market News
Brokers name 3 ASX shares to buy right now
Share Market News
ASX 200 down 0.45%: REA Group impresses, IAG profit slump, ResMed downgraded
Share Fallers
Why Australian Ethical, Northern Star, ResMed, & TPG Telecom are dropping lower
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
